Abbott Laboratories DL-Notes 2016(16/26)

Type of financial instrument

Corporate Bond

Sub-Type

Health Care

Yield

4.40

Yield spread Bundesanleihe

1.5706

Tradable for private investors

No

Minimum amount tradeable unit

2,000.00

Maturity

30/11/2026

Interest Rate

3.75 %

Currency

US Dollar

Facts & figures

Price data

TRADE PLATFORM
LAST PRICE / YIELD99.8 G / 4.400 Units
PRICE DETERMINATION TIME07/27/2026 / 04:01:34 PM
DAILY VOLUME (NOMINAL)0
YIELD SPREAD1.5706
FIXINGPRICE-
DAILY HIGH / LOW99.8199.79
PREV. DAY'S PRICE99.806 (07/24)
CHANGE DAY BEFORE
-0.01
-0.01 %
52 WEEK HIGH / LOW100.017 (02/18)99.35 (08/01)

Master Data

WKN
A189MR
ISIN
US002824BF69
SYMBOL
-
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Corporate Bond
SUB-TYPEHealth Care
ISSUER
Abbott Laboratories
S&P RATINGPlease log in to view this field
(TRADING) SEGMENT / TICKS
-/ -
TRADING HOURS
07:30:00 AM - 10:00:00 PM
INTEREST RATE
3.75 %
INTEREST RUN FROM
22/11/2016
NEXT INTEREST PAYMENT
30/05/2026
UNIT INTEREST FROM NOMINAL AMMOUNT
-
TRADING CURRENCY / NOTATION
US Dollar/ Percent
NOMINAL CURRENCY
US Dollar
SETTLEMENT CURRENCY
Euro
QUOTATION
Continuous trading
ISSUING VOLUME
3.00 Bil.
MINIMUM AMOUNT TRADEABLE UNIT
2,000.00
SMALLEST TRADEABLE UNIT
1,000.00
MATURITY
30/11/2026
MARKET MAKER
-
STEP UP/ DOWN WHEN RATING CHANGES
No
STEP UP FIXED AT ISSUE
No
STEP DOWN FIXED AT ISSUE
No
BOND CALLABLE BY THE ISSUER
Yes
BOND IS SUBORDINATED
No

Description

Local currency bond: USD. Make Whole Call Option. Callable bond.

Tradability Information

Please log in to see the tradability information for this stock.

Not registered yet? Create your free account here.

Company profile

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment focuses on branded generic pharmaceuticals that are manufactured worldwide and marketed and sold outside the United States, primarily in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternative care testing sites. The Nutritional Products segment oversees the worldwide sale of pediatric and adult nutritional products. The Medical Devices segment offers a broad range of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, as well as diabetes care and continuous glucose monitoring products. It also provides neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.